Ruggero Ridolfi
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers 35
- CAR-T cell therapy research 26
- Cutaneous Melanoma Detection and Management 19
- Immunology top 2%
- Immunotherapy and Immune Responses 46
- Immune Cell Function and Interaction 10
- T-cell and B-cell Immunology 8
- Ophthalmology top 5%
- Molecular Biology top 10%
- Melanoma and MAPK Pathways 14
- vaccines and immunoinformatics approaches 11
- Co-authors
- Laura RidolfiVanna Chiarion‐SileniDavid M. BermanAngela RiccobonOmid HamidDavid R. MinorJeffrey S. WeberHazem Assi
- Cited by
- OncologyImmunologyOphthalmology
- Journals
- Journal of Clinical Oncology (20 papers)Cancer Research (1 paper)The Lancet Oncology (1 paper)
- Partner nations
- ItalyUnited StatesIndia
In The Last Decade
Ruggero Ridolfi
91 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 87
- Oncology 1.9k
- Immunology 1.1k
- Ophthalmology 175
- Pulmonary and Respiratory Medicine 408
- Molecular Biology 774
Countries citing papers authored by Ruggero Ridolfi
This map shows the geographic impact of Ruggero Ridolfi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruggero Ridolfi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruggero Ridolfi more than expected).
Fields of papers citing papers by Ruggero Ridolfi
This network shows the impact of papers produced by Ruggero Ridolfi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruggero Ridolfi. The network helps show where Ruggero Ridolfi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ruggero Ridolfi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 128 | |
| 2 | 2012 | 26 | |
| 3 | 2012 | 45 | |
| 4 | 2011 | 14 | |
| 5 | 2011 | 27 | |
| 6 | 2011 | 45 | |
| 7 | 2011 | 100 | |
| 8 | 2010 | 15 | |
| 9 | 2009 | 460 | |
| 10 | 2008 | 18 | |
| 11 | 2006 | 7 | |
| 12 | 2004 | 18 | |
| 13 | 2004 | 100 | |
| 14 | 2003 | 17 | |
| 15 | 2003 | 2 | |
| 16 | 2001 | 67 | |
| 17 | 2001 | 27 | |
| 18 | 1998 | 20 | |
| 19 | 1994 | 5 | |
| 20 | 1991 | 24 |
About Ruggero Ridolfi
Ruggero Ridolfi is a scholar working on Oncology, Immunology and Ophthalmology, having authored 97 papers that have together received 2.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (46 papers), Cancer Immunotherapy and Biomarkers (35 papers), CAR-T cell therapy research (26 papers), Cutaneous Melanoma Detection and Management (19 papers), Melanoma and MAPK Pathways (14 papers), vaccines and immunoinformatics approaches (11 papers), Immune Cell Function and Interaction (10 papers) and T-cell and B-cell Immunology (8 papers). The work is most often cited by research in Oncology (1.9k citations), Immunology (1.1k citations) and Ophthalmology (175 citations). Ruggero Ridolfi has collaborated with scholars based in Italy, United States and India. Frequent co-authors include Laura Ridolfi, Vanna Chiarion‐Sileni, David M. Berman, Angela Riccobon, Omid Hamid, David R. Minor, Jeffrey S. Weber, Hazem Assi, Paola Queirolo and Ilan G. Ron. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.